In a St. Joseph Healthscene report, the overall cost of drugs for type 2 diabetes almost doubled between 2001 and 2007. The new drugs pushing the rise in costs are often being used as an alternative to insulin. But a new study has found there's no evidence the new medications improve care. Experts say more studies are needed to find out out whether these new therapies are worth the extra cost.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.